These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6824635)

  • 1. Adenosine deaminase: solvent isotope and pH effects on the binding of transition-state and ground-state analogue inhibitors.
    Kurz LC; Frieden C
    Biochemistry; 1983 Jan; 22(2):382-9. PubMed ID: 6824635
    [No Abstract]   [Full Text] [Related]  

  • 2. The rate of formation of transition-state analogues in the active site of adenosine deaminase is encounter-controlled: implications for the mechanism.
    Kurz LC; Moix L; Riley MC; Frieden C
    Biochemistry; 1992 Jan; 31(1):39-48. PubMed ID: 1731884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular dichroism changes in adenosine deaminase upon substrate analog binding.
    Lucacchini A; Bertucci C; Ronca G; Rossi CA
    Ital J Biochem; 1982; 31(2):107-13. PubMed ID: 7129853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition-state stabilization by adenosine deaminase: 1,6-addition of water to purine ribonucleoside, the enzyme's affinity for 6-hydroxy-1,6-dihydropurine ribonucleoside, and the effective concentration of substrate water at the active site.
    Jones W; Kurz LC; Wolfenden R
    Biochemistry; 1989 Feb; 28(3):1242-7. PubMed ID: 2713361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence from nitrogen-15 and solvent deuterium isotope effects on the chemical mechanism of adenosine deaminase.
    Weiss PM; Cook PF; Hermes JD; Cleland WW
    Biochemistry; 1987 Nov; 26(23):7378-84. PubMed ID: 3427079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of purine nucleosides by mitochondrial enzymes of bovine liver.
    Lewis RA; Link L; Chen W
    Adv Exp Med Biol; 1989; 253A():353-7. PubMed ID: 2516408
    [No Abstract]   [Full Text] [Related]  

  • 7. Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells.
    Rogler-Brown T; Agarwal RP; Parks RE
    Biochem Pharmacol; 1978; 27(19):2289-96. PubMed ID: 569482
    [No Abstract]   [Full Text] [Related]  

  • 8. A transition state in pieces: major contributions of entropic effects to ligand binding by adenosine deaminase.
    Kati WM; Acheson SA; Wolfenden R
    Biochemistry; 1992 Aug; 31(32):7356-66. PubMed ID: 1510925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine nucleoside production in mature and immature human lymphocytes.
    Dornand J; Bonnafous JC; Favero J; Mani JC
    FEBS Lett; 1982 Jun; 142(1):88-92. PubMed ID: 6286348
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextran-linked purine nucleosides as substrates and inhibitors of adenosine deaminase.
    Rosemeyer H; Körnig E; Seela F
    Eur J Biochem; 1982 Sep; 127(1):185-91. PubMed ID: 6183116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase: viscosity studies and the mechanism of binding of substrate and of ground- and transition-state analogue inhibitors.
    Kurz LC; Weitkamp E; Frieden C
    Biochemistry; 1987 Jun; 26(11):3027-32. PubMed ID: 3607008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase converts purine riboside into an analogue of a reactive intermediate: a 13C NMR and kinetic study.
    Kurz LC; Frieden C
    Biochemistry; 1987 Dec; 26(25):8450-7. PubMed ID: 3442668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new nebularine analogues and their inhibitory activity against adenosine deaminase.
    Lougiakis N; Marakos P; Pouli N; Fragopoulou E; Tenta R
    Chem Pharm Bull (Tokyo); 2015; 63(2):134-42. PubMed ID: 25748785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined 2.5 A structure of murine adenosine deaminase at pH 6.0.
    Sharff AJ; Wilson DK; Chang Z; Quiocho FA
    J Mol Biol; 1992 Aug; 226(4):917-21. PubMed ID: 1518061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent substrate analogue for adenosine deaminase: 3'-O-[5-(dimethylamino)naphthalene-1-sulfonyl]adenosine.
    Skorka G; Shuker P; Gill D; Zabicky J; Parola AH
    Biochemistry; 1981 May; 20(11):3103-9. PubMed ID: 7248272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major enhancement of the affinity of an enzyme for a transition-state analog by a single hydroxyl group.
    Kati WM; Wolfenden R
    Science; 1989 Mar; 243(4898):1591-3. PubMed ID: 2928795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser.
    Slaats EH; Asberg EG; van Keimpema AR; Kruijswijk H
    J Clin Chem Clin Biochem; 1985 Oct; 23(10):677-82. PubMed ID: 4067516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of a single hydroxyl group to transition-state discrimination by adenosine deaminase: evidence for an "entropy trap" mechanism.
    Kati WM; Wolfenden R
    Biochemistry; 1989 Sep; 28(19):7919-27. PubMed ID: 2558714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.
    Frick L; Wolfenden R; Smal E; Baker DC
    Biochemistry; 1986 Apr; 25(7):1616-21. PubMed ID: 3486673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the inhibition of adenosine deaminase.
    Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
    J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.